コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 t cell migration on fibronectin requires the integrin alpha5beta1.
2 re regulated by adhesion proteins, including integrin alpha5beta1.
3 man Fn, and the epithelial cell Fn receptor, integrin alpha5beta1.
4 as a molecular bridge between M1 protein and integrin alpha5beta1.
5 by antibodies to the endogenously expressed integrin alpha5beta1.
6 as labeled by antibodies to the RGDS-binding integrin alpha5beta1.
7 h follow ligation of Fn to its receptor, the integrin alpha5beta1.
8 orming a liquid-liquid phase separation with integrin alpha5beta1.
9 rolled by fibronectin (FN) and its receptor, integrin alpha5beta1.
10 sion to fibronectin, the canonical ligand of integrin alpha5beta1.
11 reas it cooperates with talin for activating integrin alpha5beta1.
12 recently in haptotaxis via interaction with integrin alpha5beta1.
13 Fibronectin (FN) depends on the FN receptor Integrin alpha5beta1.
14 eir survival to fibronectin by up-regulating integrin alpha5beta1.
15 (68)Ga-aquibeprin shows high selectivity for integrin alpha5beta1 (50% inhibition concentration [IC50
16 conjugated to a cyclic peptide that binds to integrin alpha5beta1, a factor that promotes osteogenesi
19 ion and metastasis through direct binding to integrin alpha5beta1, alphavbeta1, and epidermal growth
20 he related integrin alphavbeta8, but not the integrins alpha5beta1, alphavbeta3, alphavbeta5 and alph
21 ed PEAK1 as an interactor of the RGD-binding integrins alpha5beta1, alphaVbeta3, and alphaVbeta5 in f
22 70C) markedly inhibited adhesion mediated by integrins alpha5beta1, alphavbeta5, and alphavbeta6, par
23 that M4 increases expression of "migratory" integrins alpha5beta1, alphaVbeta5, and alphaVbeta6, whe
24 an antibody against the fibronectin-binding integrin alpha5beta1 also blocked the p70S6K phosphoryla
27 erm control and FGR pregnancies, we assessed integrin alpha5beta1 and alphavbeta3 regulation during c
29 oprecipitation, while direct binding between integrin alpha5beta1 and CCN2 was confirmed in cell-free
33 to investigate cellular mechanisms by which integrin alpha5beta1 and Fn1 regulate aortic arch artery
34 CCN2 regulates PSC function via cell surface integrin alpha5beta1 and heparan sulfate proteoglycan re
36 D3 coordinately regulates the expression of integrin alpha5beta1 and integrin alphavbeta3 during ang
38 serves as a mechanism for the activation of integrin alpha5beta1 and the atherogenic phenotype of EC
39 tect and differentiate between two different integrins (alpha5beta1 and alphavbeta3) bound to RGD-con
44 e recommendable for complementary mapping of integrins alpha5beta1 and alphavbeta3 by PET, allowing f
46 itional evidence of "cross-talk" between the integrins alpha5beta1 and alphavbeta3, and support the i
47 Alternatively spliced forms of CD97 bind integrins alpha5beta1 and alphavbeta3, decay acceleratin
48 are tracers for selective in vivo mapping of integrins alpha5beta1 and alphavbeta3, respectively, by
49 t adhesion response to selective ligands for integrins alpha5beta1 and alphavbeta3, which are both re
50 ich high activity toward fibronectin binding integrins alpha5beta1 and alphavbeta6 and not on vitrone
51 bronectin, whereas other fibronectin-binding integrins, alpha5beta1 and alphaVbeta3, were resident at
52 (via integrin alpha2beta1), fibronectin (via integrin alpha5beta1), and fibrinogen (via integrin alph
53 and angiogenesis via binding to its receptor integrin alpha5beta1, and enhances downstream focal adhe
54 independent manner by complexing with active integrin alpha5beta1, and mediating beta-arrestin2-depen
62 vity of FN was mediated by the activation of integrin alpha5beta1 at Tensin1-positive fibrillar adhes
63 tion of fibronectin and acute disruptions of integrin alpha5beta1 binding to fibronectin increases th
67 peptide, and novel nonpeptide antagonists of integrin alpha5beta1 blocked angiogenesis induced by sev
68 Cs blunted the anti-atheroprone effect of an integrin alpha5beta1-blocking peptide (ATN161) in Apoe-/
69 that cyclic forces applied to a fibronectin-integrin alpha5beta1 bond switch the bond from a short-l
70 al reinforcement strengthens the fibronectin-integrin alpha5beta1 bond through the RGD binding site o
71 recruitment of paxillin to sites of lateral integrin alpha5beta1 clustering and is followed by tight
72 structure of the ligand-binding headpiece of integrin alpha5beta1 complexed with fragments of its phy
77 An analysis of HUASMC fibronectin receptor (integrin alpha5beta1) distribution revealed that III1-C
79 -stain electron microscopy, we show that the integrin alpha5beta1 ectodomain adopts extended-closed a
80 nals in an NC cell-autonomous manner through integrin alpha5beta1 expressed by the NC, leading to act
85 tween the ECM component fibronectin (fn) and integrin alpha5beta1 forms a complex with ZO-1 in cells
87 show that the three conformational states of integrin alpha5beta1 have discrete free energies and def
89 determine the expression and localization of integrin alpha5beta1 in human retinal pigment epithelium
90 remodeling stem from the role of mesodermal integrin alpha5beta1 in neural crest proliferation and d
91 ate proteoglycans functioned as a partner of integrin alpha5beta1 in regulating adhesion of PSCs to C
93 demonstrate a requisite role for mesodermal integrin alpha5beta1 in signaling between the mesoderm a
95 s showed that c-Abl inhibitor attenuated the integrin alpha5beta1-induced YAP tyrosine phosphorylatio
96 ted against the epithelial cell Fn receptor, integrin alpha5beta1, inhibited Fn and FBS-mediated inva
97 by soluble endoglin, RGD peptides, the anti-integrin alpha5beta1 inhibitory antibody LIA1/2 and the
98 The complex of GM3 with tetraspanin CD9 and integrin alpha5beta1 inhibits motility and invasiveness.
99 study clarifies the binding of galectin-3 to integrin alpha5beta1, instead of advanced glycation end-
101 nment along AC processes, suggesting that FN-integrin alpha5beta1 interaction is involved in filopodi
106 the basis of our results, we suggested that integrin alpha5beta1 is involved in BK-induced signaling
111 r epithelial and A549 cells, suggesting that integrin alpha5beta1 is the major Fn receptor expressed
113 e that a major cell surface receptor for FN, integrin alpha5beta1, is also required for the developme
114 stress-induced conformational activation of integrin alpha5beta1 leading to the opening of the HC.
115 gnetic beads or conformational activation of integrin alpha5beta1 leads to the opening of the Cx43 HC
116 eted cells displayed significantly increased integrin alpha5beta1 levels, accompanied by enhanced adh
119 metry modulates cell shape, adhesion through integrin alpha5beta1, MAPK and STAT activity, and initia
120 aining peptide or antibodies recognizing the integrin alpha5beta1 markedly reduced invasion, suggesti
121 ata indicate that insulin potently activates integrin alpha5beta1 mediated CHO-T cell adhesion, while
124 gatus CalA is an invasin that interacts with integrin alpha5beta1 on host cells, induces endocytosis
127 on of this fibronectin-containing matrix via integrins alpha5beta1 or alphaVbeta3 can transfer stress
133 harmacological inhibition of the endothelial integrin alpha5beta1 recapitulated adipocyte-specific An
134 s study indicates that FN, by binding to the integrin alpha5beta1 receptor, stimulates the expression
135 ion of III13 and III7-11 (which contains the integrin alpha5beta1 recognition site), either as a sing
137 Here, we identify angiopoietin-2 (Angpt2)-integrin alpha5beta1 signaling as an inducer of fat upta
138 ngs demonstrate the critical roles of Angpt2-integrin alpha5beta1 signaling in SAT endothelium in reg
140 ha5beta1 mediated CHO-T cell adhesion, while integrin alpha5beta1 signaling in turn enhances insulin
141 ecreased with age, while binding to CD36 and integrin alpha5beta1 significantly increased with age.
142 w molecular weight, nonpeptide antagonist of integrin alpha5beta1, SJ755, can inhibit internalization
143 these established catch-bond formers is the integrin alpha5beta1, the primary receptor for fibronect
145 Purified M1 protein failed to associate with integrin alpha5beta1 unless the integrin had been prebou
146 ndothelial endoglin interacts with leukocyte integrin alpha5beta1 via its RGD motif, and this adhesio
147 ed with enhanced adhesion to fibronectin via integrin alpha5beta1 (VLA-5), but not alpha4beta1 (VLA-4
151 beta1 are cell type specific and differ from integrin alpha5beta1 when the two integrins are coexpres
152 ne expressing a single fibronectin receptor, integrin alpha5beta1, which was uniformly activated with
153 n between VEGF receptor-2 (Flk-1) and the FN integrin, alpha5beta1, which required intact FN because
154 ipitation of matrix metal-loproteinase-9 and integrin alpha5beta1, while endogenous accumulation of G
155 reduced IE binding to the receptors CD36 and integrin alpha5beta1, while hemoglobin AS did not modify
156 he extracellular domain of broadly expressed integrin alpha5beta1 with an affinity comparable to that